Please login to the form below

Not currently logged in
Email:
Password:

Eric Rhodes becomes CEO of ERS Genomics

Succeeds the company’s founder Shaun Foy in the role

ERS Genomics Eric RhodesERS Genomics, an Irish biotechnology firm, has appointed Eric Rhodes as its new chief executive officer.

He replaces co-founder Shaun Foy in the lead role, who will continue on with the company as chairman of the board.

Rhodes joins ERS Genomics from Horizon Discovery, where he served as senior vice president of research and development and chief technology officer.

In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development.

Prior to joining Horizon Discovery, Rhodes held a number of senior positions including director of business development at Sigma-Aldrich and vice president of business development and alliance management at Sangamo Biosciences.

Foy said: “With his deep understanding of the gene-editing landscape and extensive experience in marketing and commercialising gene-editing technologies, Eric is a perfect fit to help ERS Genomics accelerate our commercialisation activities.

“We are excited to welcome him to the team.”

10th June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics